Artikel ; Online: Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization,
Therapeutic advances in respiratory disease
2021 Band 15, Seite(n) 1753466621998245
Abstract: Inhalable nanostructured microparticles of simvastatin, a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor, were rationally designed for targeted pulmonary delivery as dry powder inhalers (DPIs) for the treatment of pulmonary hypertension (PH). ... ...
Abstract | Inhalable nanostructured microparticles of simvastatin, a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor, were rationally designed for targeted pulmonary delivery as dry powder inhalers (DPIs) for the treatment of pulmonary hypertension (PH). Advanced particle engineering design technology was employed to develop inhalable dry powders using different dilute feed concentrations and spray drying pump rates. Several analytical techniques were used comprehensively to characterize the physicochemical properties of the resulting powders. Scanning electron microscopy (SEM) was used to visualize particle morphology (shape), surface structure, size, and size distribution. Karl Fischer titration (KFT) was employed to quantify the residual water content in the powders. X-ray powder diffraction (XRPD) was used to determine crystallinity. Hot-stage microscopy (HSM) under cross-polarizing lens was used to observe the presence or absence of birefringence characteristic of crystallinity. Differential scanning calorimetry (DSC) was employed to quantify thermotropic phase behavior. Attenuated total reflectance (ATR)-Fourier-transform infrared (FTIR) spectroscopy and Raman spectroscopy were used to determine the molecular fingerprint of simvastatin powders before and after particle engineering design. |
---|---|
Mesh-Begriff(e) | Administration, Inhalation ; Aerosols ; Animals ; Cell Culture Techniques ; Crystallization ; Disease Models, Animal ; Drug Delivery Systems ; Dry Powder Inhalers ; Humans ; Hypertension, Pulmonary/drug therapy ; Hypertension, Pulmonary/physiopathology ; Lung/metabolism ; Lung/physiopathology ; Male ; NF-E2-Related Factor 2/drug effects ; NF-E2-Related Factor 2/metabolism ; Nanostructures ; Particle Size ; Powders ; Rats ; Rats, Sprague-Dawley ; Sheep ; Simvastatin/administration & dosage ; Simvastatin/chemistry ; Simvastatin/pharmacology ; Vascular Resistance/drug effects ; rho-Associated Kinases/antagonists & inhibitors |
Chemische Substanzen | Aerosols ; NF-E2-Related Factor 2 ; Powders ; Simvastatin (AGG2FN16EV) ; rho-Associated Kinases (EC 2.7.11.1) |
Sprache | Englisch |
Erscheinungsdatum | 2021-03-15 |
Erscheinungsland | England |
Dokumenttyp | Comparative Study ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2476459-0 |
ISSN | 1753-4666 ; 1753-4658 |
ISSN (online) | 1753-4666 |
ISSN | 1753-4658 |
DOI | 10.1177/1753466621998245 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 6753: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.